Forward Looking Statements: This documents contains statements related to our future business and financial performance and future events or developments that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forward to,” “anticipate” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project” or words of similar meaning. Such statements are based on the current expectations and certain assumptions of the Company, of which many are beyond AmeriCann’s control. These are subject to a number of risks, uncertainties and factors, particularly those that relate to governmental regulations.

AMERICANN.COinfo@americann.co

303.862.9000

DENVER OFFICE3200 Brighton Blvd, Unit 114

Denver, CO 80216

OTCQX: ACANPublicly Traded Company

Fully Reporting Audited

BOSTON OFFICEOne Boston Place, Suite 2600

Boston, MA 02108

Our belief in sustainable cultivation and processing practices — and our responsibility towards our community and environment — is driven by the core conviction that anyone who can

benefit from safe, regulated access to medical cannabis should have it.

OUR BELIEF

AmeriCann currently has over

1,000,000 square feet of cultivation facilities

in various stages of development in multiple states.

INDUSTRY GROWTHEstimated National Cannabis Sales

CURRENT REGULATED STATESFuture years are projections only based on industry expert analysis.

Actual results may vary.

Current Markets Target Markets 5

10

20

25

30

35

40

45

50

55

60$ in Billions

$45 Billion

$5.4 Billion

$22 Billion

Massachusetts750,000 sq. ft. of infrastructure52 Acre Parcel

Delaware204,000 sq. ft. of Infrastructure10 Acre Parcel

Colorado125,000 sq. ft. of Infrastructure5 Acre Parcel

2015 2020

“The secret of change is to focus all of your energy,

not on fighting the old, but on building the new.”

- SOCRATES

AmeriCann’s Preferred Partner Program supports

licensed operators in regulated markets. The Company does

not cultivate, process, distribute or sell

cannabis.

MANAGEMENT STRENGTH AmeriCann’s management team has a track record of success with both private and public companies. This team has an exceptional range of managerial expertise and skills.

EXCELLENT GROWTH POTENTIAL The Cannabis sector is recognized as the fastest growing industry in the country, with a growth rate that is projected to accelerate in the future.

STRONG EXISTING PROJECTSAmeriCann has projects in several of the most attractive markets in the country with over 1 million square feet in development.

EARLY MARKET PARTICIPANTThe Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands.

HIGH RETURN ON CAPITALAmeriCann anticipates earning high returns on its development investments with long-term triple net leases with quality, licensed operators throughout the country.

PROVEN MANAGEMENT TEAM

FAST GROWING INDUSTRY

UNIQUE INDUSTRY KNOWLEDGE

STRONG ECONOMICS

AmeriCann develops world-class facilities

for the production of medical cannabis.

Our business model allows us to support medical cannabis in

all regulated markets.

Our current opportunities are

excellent, and the future is

even brighter.

AmeriCann’s management team includes an

unprecedented level of industry experience

and depth.

CORE STRENGTHS

Forward Looking Statements: This documents contains statements related to our future business and financial performance and future events or developments that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forward to,” “anticipate” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project” or words of similar meaning. Such statements are based on the current expectations and certain assumptions of the Company, of which many are beyond AmeriCann’s control. These are subject to a number of risks, uncertainties and factors, particularly those that relate to governmental regulations.

Our team has experience from inside and outside of the cannabis industry.  AmeriCann brings professionalism and traditional horticultural and proven

business practices to the rapidly growing medical cannabis.

AMERICANN LEADERSHIP TEAM

WHO WE ARE

AMERICANN.COinfo@americann.co

303.862.9000

DENVER OFFICE3200 Brighton Blvd, Unit 114

Denver, CO 80216

OTCQX: ACANPublicly Traded Company

Fully Reporting Audited

BOSTON OFFICEOne Boston Place, Suite 2600

Boston, MA 02108

Mr. Keogh offers a unique combination of firsthand experience in the cannabis industry, from licensing to operations in numerous states, and an extensive background in real estate development. He is a director of a Provisionally Registered Marijuana Dispensary in Massachusetts and an active member and invited speaker for the National Cannabis Industry Association. Mr. Keogh received a BS in business administration from Mount St. Mary’s University.

TIM KEOGHPRESIDENT, CEO

Mr. Barton has been the managing director of a Colorado-based venture capital and private equity firm since 2006. He was the Founder of Synergy Resources, Inc. (NYSE: SYRG) and has extensive experience in the public and private capital markets. Mr. Barton has been instrumental in raising over $800 million in equity and debt financing for emerging companies over the past decade. He earned an MBA in finance from UCLA.

BEN BARTONFOUNDER, DIRECTOR, CFO

AmeriCann does not cultivate, process, distribute or sell

cannabis. Rather, we assist local partners to obtain licenses, to

cultivate medicine and to provide important medicine to patients.

AMERICANN ADVISORY BOARD

EARLY MARKET PARTICIPANT

AmeriCann plans to leverage its leadership in a formative

industry to establish a dominant position as the

cannabis industry expands.

Dr. Anderson has over 25 years’ experience in public health research design and ethics. He has been a leader in the review, funding, and commercialization of behavioral research and development, including tech-based applications for health promotion and disease prevention. Dr. Anderson was a Project Director at the National Cancer Institute (NCI;NIH) and is currently the & Human Subjects Protections Administrator for the Federally-authorized Health Media Lab Institutional Review Board (IRB) in Washington, DC. He received his Ph.D. and MPH at the University Of Minnesota School Of Public Health.

DR. D.MICHAELANDERSONMEDICAL ADVISOR

Most recently Dr. Corr managed a technical team for Syngenta responsible for providing technical advice to greenhouse facilities throughout North America. In the past he has been a faculty member at the University of Tennessee specializing in controlled-environment horticulture. Later, at the Ball Horticultural Company, he managed a research greenhouse, directed research, had responsibility for international sales and was Director of New Crop Development. In his position with Valent Biosciences he introduced a new organically-certified plant growth regulator for grape production.

BRIAN E. CORR, PHDHORTICUL-TURAL ADVISOR

Mr. Brait is a licensed attorney specializing exclusively in the legal cannabis industry since he received his law degree and has developed a through understand and knowledge of all aspects of the industry. He is the managing partner of the Denver-based Green Law Firm and a founder of the Cannabis Commodities Exchange in Colorado. He was a Distinguished Scholar at Southern Methodist University where he received his BBA in finance and BA in political science before receiving his law degree from the U. of Arizona.

NICK BRAITLICENSING & COMPLIANCE ADVISOR

Dr. Havens specializes in plant medicine and product development, with almost a decade of experience designing extraction systems, end products, conducting product and process research and creating innovative strategies for the Cannabis industry. Dr. Havens brings twenty years in alternative medicine and supplements combined with advanced training in extraction and manufacturing technology. Dr. Havens experience includes the creation of patent pending new extraction technologies and product line development for health and wellness industries.

RIEN HAVENS, PHDEXTRACTION & INFUSED PRODUCT ADVISOR

Mr. Forington is the Head of Breeding and Strain Development for 303 Seeds, a cannabis genetics and seed company based in Denver, Colorado. After several years of cannabis R&D focused on the psychoactive cannabinoid compound THC, Mr. Forington shifted his focus to non-psychoactive cannabinoids including CBD, CBG, CBC and CBN. His breeding work includes the highest lab tested cannabidiol (CBD) and cannabigerol (CBG) plant specimens known in the medical cannabis market and he has received several cannabis awards.

ERIC FORINGTON GENETICS & BREEDING ADVISOR

Forward Looking Statements: This documents contains statements related to our future business and financial performance and future events or developments that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forward to,” “anticipate” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project” or words of similar meaning. Such statements are based on the current expectations and certain assumptions of the Company, of which many are beyond AmeriCann’s control. These are subject to a number of risks, uncertainties and factors, particularly those that relate to governmental regulations.

AmeriCann, Inc. develops, owns and supports advanced medical cannabis facilities in multiple states. In an effort to advance the quality of medical cannabis and to promote greater access for patients, AmeriCann has initiated the

AmeriCann Preferred Partner Program. AmeriCann does not cultivate, process or distribute, or sell cannabis. Rather, we assist our local partners to obtain licenses, to efficiently produce medicine, and to provide important medicine to patients.

PREFERRED PARTNER PROGRAM

PREFERRED PARTNER PROGRAM MISSION STATEMENT

AMERICANN.COinfo@americann.co

303.862.9000

DENVER OFFICE3200 Brighton Blvd, Unit 114

Denver, CO 80216

OTCQX: ACANPublicly Traded Company

Fully Reporting Audited

BOSTON OFFICEOne Boston Place, Suite 2600

Boston, MA 02108

“The combination of services that AmeriCann provided our

company – cannabis expertise in conjunction with significant capital, is unprecedented in this industry.”

- JOHN RAY Managing Member of 4900 Jackson, LLC,

an AmeriCann Preferred Partner

AmeriCann supports local businesses to serve cannabis patients in their communities.

Learn more about the AmeriCann Preferred Partner Program and how we help entrepreneurs in regulated medical cannabis markets.

AmeriCann’s purpose is to fuel the growth of the medical cannabis industry and to eliminate barriers

for our partners to succeed.

AmeriCann assists partners with the

identification, design, permitting, acquisition,

development and operation of scale-able infrastructure to

limit product shortfalls in newly regulated markets.

This ensures patients have reliable access to

medical cannabis.AmeriCann provides an unmatched

combination of resources for

our partners.

EXPERTISE & EXPERIENCE The Company’s management team and advisors have an exceptional range of expertise and skills that assist AmeriCann’s partners in many essential areas.

CULTIVATION FACILITIES AmeriCann designs, builds and delivers very specialized facilities to produce the best possible medicine in the most efficient manner utilizing the most advanced, sustainable practices.

QUALITY CURRENT PROJECTSThe Company has projects in several of the most attractive markets in the country with over 1 million square feet in development.

ACCESS TO CAPITALOne of the biggest challenges facing medical cannabis providers is a lack of capital. As traditional financing sources are often unavailable, AmeriCann can provide essential funding to make the delivery of medicine to patients a reality.

INFUSED MEDICAL PRODUCTSAmeriCann provides its partners with a premier family of neutraceutical grade infused products that provide greater choice and options for their patients.

CULTIVATION EXPERTISE

REAL ESTATE DEVELOPMENT

CAPITAL

LICENSE PROCUREMENT

AREAS PROVIDED FOR PREFERRED PARTNERS

AmeriCann, Inc. develops, owns and supports advanced medical cannabis

facilities in multiple states.

In an effort to advance the quality of medical cannabis

& to promote greater access for patients, we have initiated the AmeriCann Preferred

Partner Program.

We support local businesses that seek to serve

cannabis patients in their communities.

The company provides an essential set of resources

including advanced cultivation facilities, access to a team of experts and, in certain

cases, capital for our partners’ businesses.

At AmeriCann, we can help our Preferred Partners

identify the most promising markets and help navigate

and obtain a valuable license. Additionally, we can provide

the facilities, operational supports and the capital

to help them succeed upon award of a license.